Press release
Comprehensive Allogeneic Cell Therapy Market Insights: Forecasting Size, Growth, and Competitive Trends from 2025 to 2034
Allogeneic Cell Therapy
The surge in chronic disease occurrences is anticipated to fuel the expansion of the allogeneic cell therapy market. A chronic disease is a persistent condition that often necessitates continuous healthcare and may impede daily routines or life quality. Changes in lifestyle, genetic factors, and exposure to harmful substances or pollutants contribute to the rise in chronic diseases. Allogeneic cell therapy offers a promising approach to treating a myriad of chronic illnesses by using healthy donor cells to rectify, substitute, or control defective cells or tissues in the patient. For example, data from the US National Center for Biotechnology Information (NCBI), a medical library, showed in January 2023 that the population aged 50 years and above with one or more chronic diseases is projected to surge by 99.5% by 2050, from 71.52 million in 2020 to 142.66 million. Consequently, the rising incidence of chronic diseases propels the growth of the allogeneic cell therapy market.
Get Your Allogeneic Cell Therapy Market Report Here:
https://www.thebusinessresearchcompany.com/report/allogeneic-cell-therapy-global-market-report
What growth opportunities are expected to drive the allogeneic cell therapy market's CAGR through 2034?
In recent times, there has been a significant expansion in the allogeneic cell therapy market. This market is forecasted to increase in size from $1.08 billion in 2024 to $1.2 billion in 2025, reflecting a compound annual growth rate (CAGR) of 11.9%. This growth during the historic period can be linked to a greater emphasis on customizing donor cell selection and genetic alterations, population growth, an enhanced global load of chronic diseases, heightened awareness, and a surge in partnerships for biosimilar development.
The market size for allogeneic cell therapy is set to experience swift expansion in the coming years. It is anticipated to reach a valuation of $1.86 billion in 2029, with a compound annual growth rate (CAGR) of 11.5%. Factors propelling the growth during the forecast period include an increased necessity for sophisticated medical treatments, escalating demand for innovative allogeneic cell therapies, a rising number of clinical trials, growth in patient population contributions, and escalating income brackets. Notable forecast period trends encompass technological innovation, strategic alliances, collaboration amongst large corporations, mergers and acquisitions, and the introduction of new products.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15976&type=smp
What are the emerging trends shaping the future of the allogeneic cell therapy market?
Predominant businesses within the allogeneic cell therapy market are concentrating on the creation of novel solutions - particularly, cell processing platforms - aimed at maintaining their market dominance. These platforms utilize various apparatus and technology for the preparation and alteration of cells for therapeutic use, including isolation, purification, expansion, modification and quality control processes to confirm that the cells are fit for clinical usage. For example, in March 2024, Swedish healthcare firm Getinge collaborated with UK biotech company CellRev to introduce Livit ACE, a continuous cell processing (Adherent Cell Expansion) platform. This cutting-edge platform amalgamates technological automation and bioprocessing advancements, significantly boosting the productivity and scalability of cell production. Its distinctive features entail high-tech cell isolation and purification systems which guarantee high cell purity and viability, potent expansion capacities for the production of vast amounts of therapeutic cells, complex genetic modification instruments for accurate cell engineering, and stringent quality control procedures ensuring the safety and effectiveness of cell products.
Which growth-oriented segments of the allogeneic cell therapy market are leading the industry's development?
The allogeneic cell therapy market covered in this report is segmented -
1) By Type: Stem Cell Therapies, Non-Stem Cell Therapies
2) By Therapeutic Area: Hematological Disorders, Dermatological Disorders, Other Therapeutic Area
3) By End User: Hospitals, Specialty Clinics, Research Organizations
Subsegments:
1) By Stem Cell Therapies: Hematopoietic Stem Cell Therapy (Hematopoietic Stem Cells), Mesenchymal Stem Cell Therapy (MSC-Based Therapies), Induced Pluripotent Stem Cells (iPSC-Based Therapies), Neural Stem Cell Therapy, Other Stem Cell Therapies
2) By Non-Stem Cell Therapies: T-cell Therapies, Natural Killer (NK) Cell Therapies, Dendritic Cell Therapies, Other Non-Stem Cell Therapies
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15976
What regions are leading the charge in the allogeneic cell therapy market?
North America was the largest region in the allogeneic cell therapy market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the allogeneic cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What companies are at the forefront of innovation in the allogeneic cell therapy market?
Major companies operating in the allogeneic cell therapy market are Novartis AG, Bristol Myers Squibb Company, Takeda Pharmaceutical Company Limited, Bluebird Bio Inc., Poseida Therapeutics Inc., Fate Therapeutics Inc., Fortress Biotech Inc., Sorrento Therapeutics Inc., Eureka Therapeutics Inc., Juno Therapeutics Inc., Adaptimmune Therapeutics plc, Cellectis SA, TrakCel Ltd., Promab Biotechnologies Inc., Ziopharm Oncology Inc., Allogene Therapeutics Inc., Century Therapeutics Inc., Autolus Therapeutics plc, Bellicum Pharmaceuticals Inc., Minerva Biotechnologies Corporation, Celyad SA, TILT Biotherapeutics Ltd., CRISPR Therapeutics AG
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=15976&type=smp
What Is Covered In The Allogeneic Cell Therapy Global Market Report?
•Market Size Forecast: Examine the allogeneic cell therapy market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the allogeneic cell therapy market for a structured understanding.
•Key Players Overview: Analyze major players in the allogeneic cell therapy market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the allogeneic cell therapy market.
•Segment Contributions: Evaluate how different segments drive overall growth in the allogeneic cell therapy market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the allogeneic cell therapy market.
•Industry Challenges: Identify potential risks and obstacles affecting the allogeneic cell therapy market.
•Competitive Landscape: Review strategic developments in the allogeneic cell therapy market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Comprehensive Allogeneic Cell Therapy Market Insights: Forecasting Size, Growth, and Competitive Trends from 2025 to 2034 here
News-ID: 3922851 • Views: …
More Releases from The Business Research Company
2025-2034 Mainframe Modernization Market Evolution: Emerging Opportunities and M …
What Is the Projected Size of the Mainframe Modernization Market by 2025?
Recent years have witnessed substantial expansion in the market dedicated to mainframe modernization, with projections indicating a climb from a valuation of $15.72 billion in 2024 up to $18.12 billion by 2025, a trajectory translating to a compound annual growth rate (CAGR) of 15.2%. This historical upward trend is fueled by several key factors, chief among them being escalating…
Accelerated Digital Transformation Fuels Expansion in the Liquid Crystal Polymer …
How Much Will the Liquid Crystal Polymer (LCP)-Based Molded Interconnect Device Market Size Increase by 2025?
The market for liquid crystal polymer (LCP)-based molded interconnect devices has experienced swift augmentation recently, projected to escalate from a value of $0.64 billion in 2024 to $0.75 billion in 2025, reflecting a compound annual growth rate (CAGR) of 17.3%. This historical expansion is largely traceable to several key factors, including the wider acceptance of…
Consistent Growth Projected for Land-Based Command, Control, Communications, Com …
How Much Is the Land-Based Command, Control, Communications, Computers, Intelligence, Surveillance, And Reconnaissance( C4ISR ) Market Expected to Expand by 2025?
The terrestrial C4ISR sector has experienced robust expansion lately, projected to increase its valuation from $32.64 billion in 2024 to $34.87 billion the following year, reflecting a steady compound annual growth rate of 6.8%. This upward trajectory in the past phase is traceable to several key factors, including a more…
Surging Application Across End Users Powers the Expansion of the Intelligent Ele …
How Large Is the Intelligent Electrical Panel Market Expected to Be by 2025?
The electrical panel segment characterized by intelligence has experienced swift expansion recently, projected to escalate its valuation from a total of $4.47 billion in the year 2024 to $4.95 billion by 2025, demonstrating a compound annual growth rate (CAGR) of 10.7%; this upward trajectory throughout the preceding period is linked to several factors, namely the escalating need for…
More Releases for Cell
Cell Sorting Market Accelerates as Cell Therapy, Immuno-Oncology & Single-Cell R …
The rising focus on precision medicine, immunotherapy, and advanced cell-based research is driving the global cell sorting market into a high-growth phase. With expanding applications in stem cell therapy, CAR-T manufacturing, cancer immunology, and single-cell genomics, demand for accurate, high-purity cell isolation systems is stronger than ever. This release highlights key market trends, segmentation insights, technological innovations, and the factors shaping the future of cell sorting.
Download Full PDF Sample Copy…
Cell Isolation Cell Separation Market Size Analysis by Application, Type, and Re …
According to Market Research Intellect, the global Cell Isolation Cell Separation market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period.
The market for cell isolation and separation is expanding rapidly as a result of sophisticated biotechnological…
Cell Free Protein Synthesis Market Beyond the Cell: Revolutionizing Protein Prod …
Cell-Free Protein Synthesis Market to reach over USD 457.13 Mn by the year 2031 - Exclusive Report by InsightAce Analytic
"Cell-Free Protein Synthesis Market" in terms of revenue was estimated to be worth $265.94 Mn in 2023 and is poised to reach $457.13 Mn by 2031, growing at a CAGR of 7.20% from 2024 to 2031 according to a new report by InsightAce Analytic.
Request for free Sample Pages: https://www.insightaceanalytic.com/request-sample/1445
Current…
Cell Expansion Market - Expand the Boundaries of Cell Therapy: Redefine Cell Exp …
Newark, New Castle, USA: The "Cell Expansion Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Cell Expansion Market: https://www.growthplusreports.com/report/cell-expansion-market/7939
This latest report researches the industry structure, sales, revenue,…
Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports.
This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions.
This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type…
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer.
Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u
Top Key Players: -
Becton,
Dickinson and Company
Biospherix
EMD Millipore
Eppendorf AG
Merck KGaA
Sartorius AG
VWR International
Cell culture is a rapidly emerging…
